27 results

cloudybrussels
Business Value

Posted on 23.05.2013

New rules, new markets – medical devices and diagnostics’ place in a changing Europe

Judging by the weather in Belgium (currently 10° and raining) you wouldn’t say it, but it’s almost summer. Well, at least according to the calendar. And apart from the supposed good weather, summer also brings with it a host of new information on the MedTech Forum. Speakers are being confirmed, registrations coming in and preparations being made. Less than 5 months from now, we will all be seeing each other again at the event no one in our industry can afford to miss. So what does the MedTech Forum hold in store this year.

By Serge Bernasconi Chief Executive Officer, MedTech Europe

ethicshcps
Ethics

Posted on 26.04.2012

Ethics and compliance in the MedTech industry: on the agenda in Stockholm

For medtech companies, interacting with Healthcare Professionals (HCPs) is a fact of life. HCPs are an integral part of the R&D process and a source of innovation and creativity throughout the development of medical devices. HCPs are also the prime users of technologies and play an instrumental role in the successful adoption of innovative medical devices in Europe, the US and beyond. With the adoption of new anti-bribery laws in a number of countries, increasing enforcement and new pressures from investors and the general public, the International Medical Device Industry Compliance Conference on 9-11 May in Stockholm, is well-timed to provide a platform for stakeholders to discuss these mounting challenges.

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

USglobalcompliance
Ethics

Posted on 04.05.2011

How we in the U.S. see global compliance challenges for MedTech companies

AdvaMed and Eucomed are co-organizing the upcoming International Medical Device Industry Compliance Conference, taking place on 18-20 May in London. Both AdvaMed and Eucomed worked closely with our member companies to identify the hottest issues in medical device industry compliance today to shape a truly global, industry specific event. We also worked together to invite accomplished discussion leaders and moderators, and panel participants representing North American and European perspectives and experiences.

By Christopher White General Counsel, AdvaMed

betterwatchout
Regulation

Posted on 17.12.2010

You better watch out!

Yesterday, we, at Eucomed, had our Christmas party (Happy Christmas everybody and a big thank you to all the Eucomed members and staff for everything in 2010!!). And while thinking back at yesterday’s little get-together, it’s dawning on me that with 2011 just around the corner we will be just over two and half years since the original public consultation on the recast of the EU medical devices legislation.

By John Brennan Director Regulations and Industrial Policy

autumn
Business Value

Posted on 22.10.2010

Fall leaves are dropping and hopes of reform too?

A year on and the mood music in Washington is very different. My return to this beautiful city, where fall colours are emerging in their full majesty, has seen a very different atmosphere from a year ago when the Obama health reforms were on their way and universal coverage seemed a very real probability. The […]

By John Wilkinson Former Chief Executive of Eucomed

globalharmonisation
Global Regulation

Posted on 21.10.2010

Can we move global harmonisation to the next level?

Proponents of greater regulatory harmonisation and cooperation will have been heartened by FDA chief Peggy Hamburg’s comments at the Advamed 2010 conference on Wednesday 20 October. She was quick to acknowledge that, in a changing world with vastly increased trade, the FDA could not continue to operate on an old-fashioned model designed for a time […]

By John Wilkinson Former Chief Executive of Eucomed

advamed2009
Value

Posted on 14.10.2009

John Wilkinson at AdvaMed 2009: A view on the US health reforms

A chill wind is blowing through Washington D.C. this morning and it is not just the cold front from the North blowing away the warm Autumn sun of yesterday. Yesterday, the Obama health reforms took their first step on a long and perilous road through the legislature when the Senate Finance Committee passed the preliminary […]

By John Wilkinson Former Chief Executive of Eucomed

problemorsolution
Value

Posted on 16.07.2009

Are we the problem or the solution?

Browsing the news pages of the web I came across an article in a journal that I am not familiar with from the USA, the grandly titled U.S. News & World Report. The report headed off on a familiar and now even more fashionable track of squarely identifying our industry as the villains of the […]

By John Wilkinson Former Chief Executive of Eucomed

hc-inno
Business

Posted on 29.05.2009

2009 Hauptstadtkongress debates affordability of innovation for the German healthcare system

Is innovation still affordable with increasingly strained healthcare budgets? How can medical innovations continued to be financed? Panelist of the round table of distinguished speakers Member of the European Parliament Jorgo Chatzimarkakis made a statement which nicely complements the study released by AdvaMed only 2 days ago. He said that innovation does not increase costs […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed